CyMedica Orthopedics has raised $3 million in a new round of debt and options financing, according to a recently posted SEC filing.
Money in the round comes from 2 unnamed investors, with the first sale noted on September 26, according to the filing.
The Scottsdale, Ariz.-based company is looking for an additional $2 million before closing the round, which would bring the total raised up to $5 million, according to the filing.
CyMedica has not yet officially said how it plans to use funds raised.
In April, CyMedica said that it enrolled the 1st patient in a clinical trial of its E-Vive neuro-muscular device, looking to explore its effectiveness in post-operative primary total knee arthroplasty rehabilitation.